CLEVELAND, Sept. 29, 2022 /PRNewswire/ -- Checkpoint Surgical today announced the addition of CHECKPOINT GEMINI™ to the company's industry-leading line of intraoperative nerve stimulators.

Checkpoint Surgical’s state of the art nerve stimulation devices inform intraoperative decision making to help surgeons safely and effectively protect, assess and repair motor nerves during surgery.

Checkpoint Surgical introduced the original Checkpoint Nerve Stimulator in 2009, inspiring surgeons to think differently about nerve protection and repair procedures.

Study Demonstrates Safety and Reliability of Checkpoint Nerve Stimulator/Locator for Neural Monitoring in Thyroid Surgery Scan the QR code to read the abstract and access the full article.

Checkpoint Surgical, Inc., a U.S.-based medical device company with proprietary neurostimulation technology for nerve protection and repair, announced the publication of the first peer-reviewed ...

Checkpoint Surgical Inc., a privately held company in Independence that produces nerve-stimulation medical devices, has a new CEO. The company on Wednesday, Sept. 7, announced in a news release that ...

Checkpoint Surgical Inc., a privately held company in Independence that produces nerve-stimulation medical devices, has hit an important point in the advancement of its nerve regeneration technology.

About Checkpoint Surgical, Inc. Checkpoint Surgical was established in 2009 to market the Checkpoint ® Nerve Stimulator, a device designed to help surgeons locate, protect and assess nerves ...